<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36077261</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>17</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>30</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Selenoprotein P Concentrations in the Cerebrospinal Fluid and Serum of Individuals Affected by Amyotrophic Lateral Sclerosis, Mild Cognitive Impairment and Alzheimer's Dementia.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">9865</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms23179865</ELocationID><Abstract><AbstractText>Selenoprotein P, a selenium-transporter protein, has been hypothesized to play a role in the etiology of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer's dementia (AD). However, data in humans are scarce and largely confined to autoptic samples. In this case-control study, we determined selenoprotein P concentrations in both the cerebrospinal fluid (CSF) and the serum of 50 individuals diagnosed with ALS, 30 with AD, 54 with mild cognitive impairment (MCI) and of 30 controls, using sandwich enzyme-linked immunosorbent assay (ELISA) methods. We found a positive and generally linear association between CSF and serum selenoprotein P concentrations in all groups. CSF selenoprotein P and biomarkers of neurodegeneration were positively associated in AD, while for MCI, we found an inverted-U-shaped relation. CSF selenoprotein P concentrations were higher in AD and MCI than in ALS and controls, while in serum, the highest concentrations were found in MCI and ALS. Logistic and cubic spline regression analyses showed an inverse association between CSF selenoprotein P levels and ALS risk, and a positive association for AD risk, while an inverted-U-shaped relation with MCI risk emerged. Conversely, serum selenoprotein P concentrations were positively associated with risk of all conditions but only in their lower range. Overall, these findings indicate some abnormalities of selenoprotein P concentrations in both the central nervous system and blood associated with ALS and neurocognitive disorders, though in different directions. These alterations may reflect either phenomena of etiologic relevance or disease-induced alterations of nutritional and metabolic status.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Urbano</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1490-5508</Identifier><AffiliationInfo><Affiliation>CREAGEN-Environmental, Genetic and Nutritional Epidemiology Research Center, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 287 Via Campi, 41125 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vinceti</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0551-2473</Identifier><AffiliationInfo><Affiliation>CREAGEN-Environmental, Genetic and Nutritional Epidemiology Research Center, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 287 Via Campi, 41125 Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neurosciences and Neurotechnology, Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, 287 Via Campi, 41125 Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Boston University School of Public Health, 715 Albany Street, Boston, MA 02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandrioli</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9244-9782</Identifier><AffiliationInfo><Affiliation>Center for Neurosciences and Neurotechnology, Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, 287 Via Campi, 41125 Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Unit, Azienda Ospedaliero Universitaria di Modena, 71 Via del Pozzo, 41121 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiari</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurology Unit, Azienda Ospedaliero Universitaria di Modena, 71 Via del Pozzo, 41121 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filippini</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-2100-0344</Identifier><AffiliationInfo><Affiliation>CREAGEN-Environmental, Genetic and Nutritional Epidemiology Research Center, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 287 Via Campi, 41125 Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neurosciences and Neurotechnology, Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, 287 Via Campi, 41125 Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health, University of California Berkeley, 1995 University Avenue, Berkeley, CA 94704, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bedin</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Neurosciences and Neurotechnology, Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, 287 Via Campi, 41125 Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Unit, Azienda Ospedaliero Universitaria di Modena, 71 Via del Pozzo, 41121 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tondelli</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Neurosciences and Neurotechnology, Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, 287 Via Campi, 41125 Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Unit, Azienda Ospedaliero Universitaria di Modena, 71 Via del Pozzo, 41121 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simonini</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-5456-2365</Identifier><AffiliationInfo><Affiliation>Center for Neurosciences and Neurotechnology, Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, 287 Via Campi, 41125 Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Unit, Azienda Ospedaliero Universitaria di Modena, 71 Via del Pozzo, 41121 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamboni</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-6133-3373</Identifier><AffiliationInfo><Affiliation>Center for Neurosciences and Neurotechnology, Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, 287 Via Campi, 41125 Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Unit, Azienda Ospedaliero Universitaria di Modena, 71 Via del Pozzo, 41121 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>Misaki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Biology and Metabolism, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saito</LastName><ForeName>Yoshiro</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-0559-5889</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Biology and Metabolism, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Dipartimenti di Eccellenza 2018-2022</GrantID><Agency>Italian Ministry of Education, University and Research</Agency><Country/></Grant><Grant><GrantID>UNIMORE FAR 2020 and 2021</GrantID><Agency>Mission Oriented Linea FOMO-Fondazione di Modena</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051149">Selenoprotein P</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051149" MajorTopicYN="N">Selenoprotein P</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">mild cognitive impairment</Keyword><Keyword MajorTopicYN="N">selenium</Keyword><Keyword MajorTopicYN="N">selenoprotein P</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36077261</ArticleId><ArticleId IdType="pmc">PMC9456314</ArticleId><ArticleId IdType="doi">10.3390/ijms23179865</ArticleId><ArticleId IdType="pii">ijms23179865</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goutman S.A., Hardiman O., Al-Chalabi A., Chi&#xf3; A., Savelieff M.G., Kiernan M.C., Feldman E.L. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21:465&#x2013;479. doi: 10.1016/s1474-4422(21)00414-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(21)00414-2</ArticleId><ArticleId IdType="pubmed">35334234</ArticleId></ArticleIdList></Reference><Reference><Citation>Erkkinen M.G., Kim M.-O., Geschwind M.D. Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. Cold Spring Harb. Perspect. Biol. 2017;10:a033118. doi: 10.1101/cshperspect.a033118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a033118</ArticleId><ArticleId IdType="pmc">PMC5880171</ArticleId><ArticleId IdType="pubmed">28716886</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y., Dan X., Babbar M., Wei Y., Hasselbalch S.G., Croteau D.L., Bohr V.A. Ageing as a risk factor for neurodegenerative disease. Nat. Rev. Neurol. 2019;15:565&#x2013;581. doi: 10.1038/s41582-019-0244-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0244-7</ArticleId><ArticleId IdType="pubmed">31501588</ArticleId></ArticleIdList></Reference><Reference><Citation>Baird K., Baillon S., Lau L.S.L., Storey M., Lindesay J., Velayudhan L. Predictive Factors for Conversion to Dementia in Individuals with Early-Onset Mild Cognitive Impairment. Dement. Geriatr. Cogn. Disord. 2021;50:548&#x2013;553. doi: 10.1159/000520882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000520882</ArticleId><ArticleId IdType="pubmed">34937020</ArticleId></ArticleIdList></Reference><Reference><Citation>Overton M., Pihlsg&#xe5;rd M., Elmst&#xe5;hl S. Diagnostic Stability of Mild Cognitive Impairment, and Predictors of Reversion to Normal Cognitive Functioning. Dement. Geriatr. Cogn. Disord. 2019;48:317&#x2013;329. doi: 10.1159/000506255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000506255</ArticleId><ArticleId IdType="pubmed">32224608</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M., Bottecchi I., Fan A., Finkelstein Y., Mandrioli J. Are environmental exposures to selenium, heavy metals, and pesticides risk factors for amyotrophic lateral sclerosis? Rev. Environ. Health. 2012;27:19&#x2013;41. doi: 10.1515/reveh-2012-0002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/reveh-2012-0002</ArticleId><ArticleId IdType="pubmed">22755265</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini T., Adani G., Malavolti M., Garuti C., Cilloni S., Vinceti G., Zamboni G., Tondelli M., Galli C., Costa M., et al. Dietary Habits and Risk of Early-Onset Dementia in an Italian Case-Control Study. Nutrients. 2020;12:3682. doi: 10.3390/nu12123682.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12123682</ArticleId><ArticleId IdType="pmc">PMC7760835</ArticleId><ArticleId IdType="pubmed">33260315</ArticleId></ArticleIdList></Reference><Reference><Citation>Adani G., Filippini T., Garuti C., Malavolti M., Vinceti G., Zamboni G., Tondelli M., Galli C., Costa M., Vinceti M., et al. Environmental Risk Factors for Early-Onset Alzheimer&#x2019;s Dementia and Frontotemporal Dementia: A Case-Control Study in Northern Italy. Int. J. Environ. Res. Public Health. 2020;17:7941. doi: 10.3390/ijerph17217941.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17217941</ArticleId><ArticleId IdType="pmc">PMC7663191</ArticleId><ArticleId IdType="pubmed">33138082</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini T., Tesauro M., Fiore M., Malagoli C., Consonni M., Violi F., Iacuzio L., Arcolin E., Conti G.O., Cristaldi A., et al. Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study. Int. J. Environ. Res. Public Health. 2020;17:2882. doi: 10.3390/ijerph17082882.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17082882</ArticleId><ArticleId IdType="pmc">PMC7216189</ArticleId><ArticleId IdType="pubmed">32331298</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini T., Fiore M., Tesauro M., Malagoli C., Consonni M., Violi F., Arcolin E., Iacuzio L., Oliveri Conti G., Cristaldi A., et al. Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study. Int. J. Environ. Res. Public Health. 2020;17:857. doi: 10.3390/ijerph17030857.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17030857</ArticleId><ArticleId IdType="pmc">PMC7037077</ArticleId><ArticleId IdType="pubmed">32019087</ArticleId></ArticleIdList></Reference><Reference><Citation>Aloizou A.-M., Siokas V., Vogiatzi C., Peristeri E., Docea A.O., Petrakis D., Provatas A., Folia V., Chalkia C., Vinceti M., et al. Pesticides, cognitive functions and dementia: A review. Toxicol. Lett. 2020;326:31&#x2013;51. doi: 10.1016/j.toxlet.2020.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxlet.2020.03.005</ArticleId><ArticleId IdType="pubmed">32145396</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M., Bonvicini F., Rothman K.J., Vescovi L., Wang F. The relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: A population-based case-control study. Environ. Health. 2010;9:77. doi: 10.1186/1476-069x-9-77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-069x-9-77</ArticleId><ArticleId IdType="pmc">PMC3023780</ArticleId><ArticleId IdType="pubmed">21134276</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalke B., Berthele A. Contribution to selenium speciation in cerebrospinal fluid samples. J. Anal. At. Spectrom. 2010;26:165&#x2013;170. doi: 10.1039/c0ja00106f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c0ja00106f</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M., Filippini T., Wise L.A. Environmental Selenium and Human Health: An Update. Curr. Environ. Health Rep. 2018;5:464&#x2013;485. doi: 10.1007/s40572-018-0213-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40572-018-0213-0</ArticleId><ArticleId IdType="pubmed">30280317</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M., Filippini T., Cilloni S., Bargellini A., Vergoni A.V., Tsatsakis A., Ferrante M. Health risk assessment of environmental selenium: Emerging evidence and challenges. Mol. Med. Rep. 2017;15:3323&#x2013;3335. doi: 10.3892/mmr.2017.6377.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.6377</ArticleId><ArticleId IdType="pmc">PMC5428396</ArticleId><ArticleId IdType="pubmed">28339083</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M., Mandrioli J., Borella P., Michalke B., Tsatsakis A., Finkelstein Y. Selenium neurotoxicity in humans: Bridging laboratory and epidemiologic studies. Toxicol. Lett. 2014;230:295&#x2013;303. doi: 10.1016/j.toxlet.2013.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxlet.2013.11.016</ArticleId><ArticleId IdType="pubmed">24269718</ArticleId></ArticleIdList></Reference><Reference><Citation>Naderi M., Puar P., Zonouzi-Marand M., Chivers D.P., Niyogi S., Kwong R.W. A comprehensive review on the neuropathophysiology of selenium. Sci. Total Environ. 2020;767:144329. doi: 10.1016/j.scitotenv.2020.144329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2020.144329</ArticleId><ArticleId IdType="pubmed">33445002</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M., Wei E., Malagoli C., Bergomi M., Vivoli G. Adverse Health Effects of Selenium in Humans. Rev. Environ. Health. 2001;16:233&#x2013;251. doi: 10.1515/reveh.2001.16.4.233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/reveh.2001.16.4.233</ArticleId><ArticleId IdType="pubmed">12041880</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris J.S., Crane S.B. Selenium Toxicity from a Misformulated Dietary Supplement, Adverse Health Effects, and the Temporal Response in the Nail Biologic Monitor. Nutrients. 2013;5:1024&#x2013;1057. doi: 10.3390/nu5041024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu5041024</ArticleId><ArticleId IdType="pmc">PMC3705333</ArticleId><ArticleId IdType="pubmed">23538937</ArticleId></ArticleIdList></Reference><Reference><Citation>Rae W., Kitley J., Pinto A. Selenium Toxicity Associated With Reversible Leukoencephalopathy and Cortical Blindness. JAMA Neurol. 2018;75:1282&#x2013;1283. doi: 10.1001/jamaneurol.2018.1669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.1669</ArticleId><ArticleId IdType="pubmed">29971355</ArticleId></ArticleIdList></Reference><Reference><Citation>Solovyev N., Drobyshev E., Blume B., Michalke B. Selenium at the neural barriers: A review. Front. Neurosci. 2021;15:630016. doi: 10.3389/fnins.2021.630016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.630016</ArticleId><ArticleId IdType="pmc">PMC7892976</ArticleId><ArticleId IdType="pubmed">33613188</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso B.R., Roberts B.R., Bush A.I., Hare D.J. Selenium, selenoproteins and neurodegenerative diseases. Metallomics. 2015;7:1213&#x2013;1228. doi: 10.1039/c5mt00075k.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c5mt00075k</ArticleId><ArticleId IdType="pubmed">25996565</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweizer U., Fabiano M. Selenoproteins in brain development and function. Free Radic. Biol. Med. 2022;190:105&#x2013;115. doi: 10.1016/j.freeradbiomed.2022.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2022.07.022</ArticleId><ArticleId IdType="pubmed">35961466</ArticleId></ArticleIdList></Reference><Reference><Citation>Varlamova E.G., Gudkov S.V., Plotnikov E.Y., Turovsky E.A. Size-Dependent Cytoprotective Effects of Selenium Nanoparticles during Oxygen-Glucose Deprivation in Brain Cortical Cells. Int. J. Mol. Sci. 2022;23:7464. doi: 10.3390/ijms23137464.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23137464</ArticleId><ArticleId IdType="pmc">PMC9267189</ArticleId><ArticleId IdType="pubmed">35806466</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil H.M., Azouz R.A., Hozyen H.F., Aljuaydi S.H., AbuBakr H.O., Emam S.R., Al-Mokaddem A.K. Selenium nanoparticles impart robust neuroprotection against deltamethrin-induced neurotoxicity in male rats by reversing behavioral alterations, oxidative damage, apoptosis, and neuronal loss. NeuroToxicology. 2022;91:329&#x2013;339. doi: 10.1016/j.neuro.2022.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2022.06.006</ArticleId><ArticleId IdType="pubmed">35753508</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilela D.D., Justino A.B., Caixeta D.C., de Souza A.V., Teixeira R.R., Franco R.R., Saraiva A.L., Fonseca B.B., Dantas N.O., Silva A.C.A., et al. Increased selenium concentration in the synthesis of CdSe m agic-sized quantum dots affects how the brain responds to oxidative stress. J. Biomed. Mater. Res. Part B Appl. Biomater. 2021;110:1140&#x2013;1150. doi: 10.1002/jbm.b.34988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbm.b.34988</ArticleId><ArticleId IdType="pubmed">34928544</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashir D.W., Rashad M.M., Ahmed Y.H., Drweesh E.A., Elzahany E.A., Abou-El-Sherbini K.S., El-Leithy E.M. The ameliorative effect of nanoselenium on histopathological and biochemical alterations induced by melamine toxicity on the brain of adult male albino rats. NeuroToxicology. 2021;86:37&#x2013;51. doi: 10.1016/j.neuro.2021.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2021.06.006</ArticleId><ArticleId IdType="pubmed">34216684</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuster E., Candela H., Est&#xe9;vez J., Vilanova E., Sogorb M.A. A Transcriptomic Analysis of T98G Human Glioblastoma Cells after Exposure to Cadmium-Selenium Quantum Dots Mainly Reveals Alterations in Neuroinflammation Processes and Hypothalamus Regulation. Int. J. Mol. Sci. 2022;23:2267. doi: 10.3390/ijms23042267.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23042267</ArticleId><ArticleId IdType="pmc">PMC8877384</ArticleId><ArticleId IdType="pubmed">35216387</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N., Qu G., Wen R., Liu X., Wang Y., Gao J., Yin Y., Shi J., Zhou Q., He B., et al. Occurrence of silver-containing particles in rat brains upon intranasal exposure of silver nanoparticles. Metallomics. 2022;14:mfab077. doi: 10.1093/mtomcs/mfab077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/mtomcs/mfab077</ArticleId><ArticleId IdType="pubmed">34982823</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito Y. Selenium transport mechanism via selenoprotein P-Its physiological role and related diseases. Front. Nutr. 2021;8:685517. doi: 10.3389/fnut.2021.685517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.685517</ArticleId><ArticleId IdType="pmc">PMC8193087</ArticleId><ArticleId IdType="pubmed">34124127</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsutsumi R., Saito Y. Selenoprotein P; P for Plasma, Prognosis, Prophylaxis, and More. Biol. Pharm. Bull. 2020;43:366&#x2013;374. doi: 10.1248/bpb.b19-00837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.b19-00837</ArticleId><ArticleId IdType="pubmed">32115498</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito Y. Selenoprotein P as an in vivo redox regulator: Disorders related to its deficiency and excess. J. Clin. Biochem. Nutr. 2020;66:1&#x2013;7. doi: 10.3164/jcbn.19-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.3164/jcbn.19-31</ArticleId><ArticleId IdType="pmc">PMC6983434</ArticleId><ArticleId IdType="pubmed">32001950</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M., Filippini T., Jablonska E., Saito Y., Wise L.A. Safety of selenium exposure and limitations of selenoprotein maximization: Molecular and epidemiologic perspectives. Environ. Res. 2022;211:113092. doi: 10.1016/j.envres.2022.113092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2022.113092</ArticleId><ArticleId IdType="pubmed">35259406</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito Y., Takahashi K. Characterization of selenoprotein P as a selenium supply protein. JBIC J. Biol. Inorg. Chem. 2002;269:5746&#x2013;5751. doi: 10.1046/j.1432-1033.2002.03298.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1432-1033.2002.03298.x</ArticleId><ArticleId IdType="pubmed">12423375</ArticleId></ArticleIdList></Reference><Reference><Citation>Mita Y., Uchida R., Yasuhara S., Kishi K., Hoshi T., Matsuo Y., Yokooji T., Shirakawa Y., Toyama T., Urano Y., et al. Identification of a novel endogenous long non-coding RNA that inhibits selenoprotein P translation. Nucleic Acids Res. 2021;49:6893&#x2013;6907. doi: 10.1093/nar/gkab498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab498</ArticleId><ArticleId IdType="pmc">PMC8266573</ArticleId><ArticleId IdType="pubmed">34142161</ArticleId></ArticleIdList></Reference><Reference><Citation>Misu H., Takamura T., Takayama H., Hayashi H., Matsuzawa-Nagata N., Kurita S., Ishikura K., Ando H., Takeshita Y., Ota T., et al. A Liver-Derived Secretory Protein, Selenoprotein P, Causes Insulin Resistance. Cell Metab. 2010;12:483&#x2013;495. doi: 10.1016/j.cmet.2010.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2010.09.015</ArticleId><ArticleId IdType="pubmed">21035759</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi N., Satoh K., Satoh T., Yaoita N., Siddique M.A.H., Omura J., Kurosawa R., Nogi M., Sunamura S., Miyata S., et al. Diagnostic and Prognostic Significance of Serum Levels of SeP (Selenoprotein P) in Patients With Pulmonary Hypertension. Arter. Thromb. Vasc. Biol. 2019;39:2553&#x2013;2562. doi: 10.1161/ATVBAHA.119.313267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.119.313267</ArticleId><ArticleId IdType="pubmed">31665907</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi N., Satoh K., Kurosawa R., Yaoita N., Al Mamun E., Siddique M.A.H., Omura J., Satoh T., Nogi M., Sunamura S., et al. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension. Circulation. 2018;138:600&#x2013;623. doi: 10.1161/circulationaha.117.033113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circulationaha.117.033113</ArticleId><ArticleId IdType="pubmed">29636330</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeishi R., Misaka T., Ichijo Y., Ishibashi S., Matsuda M., Yamadera Y., Ohara H., Sugawara Y., Hotsuki Y., Watanabe K., et al. Increases in hepatokine selenoprotein P levels are associated with hepatic hypoperfusion and predict adverse prognosis in patients with heart failure. J. Am. Heart Assoc. 2022;11:e024901. doi: 10.1161/JAHA.121.024901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.024901</ArticleId><ArticleId IdType="pmc">PMC9238692</ArticleId><ArticleId IdType="pubmed">35621211</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamoshita K., Tsugane H., Ishii K.-A., Takayama H., Yao X., Abuduwaili H., Tanida R., Taniguchi Y., Oo H.K., Gafiyatullina G., et al. Lauric acid impairs insulin-induced Akt phosphorylation by upregulating SELENOP expression via HNF4&#x3b1; induction. Am. J. Physiol. Metab. 2022;322:E556&#x2013;E568. doi: 10.1152/ajpendo.00163.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00163.2021</ArticleId><ArticleId IdType="pubmed">35499234</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellinger F.P., He Q.-P., Bellinger M.T., Lin Y., Raman A.V., White L.R., Berry M.J. Association of Selenoprotein P with Alzheimer&#x2019;s Pathology in Human Cortex. J. Alzheimer&#x2019;s Dis. 2008;15:465&#x2013;472. doi: 10.3233/JAD-2008-15313.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2008-15313</ArticleId><ArticleId IdType="pmc">PMC2695562</ArticleId><ArticleId IdType="pubmed">18997300</ArticleId></ArticleIdList></Reference><Reference><Citation>Solovyev N., Drobyshev E., Bj&#xf8;rklund G., Dubrovskii Y., Lysiuk R., Rayman M.P. Selenium, selenoprotein P, and Alzheimer&#x2019;s disease: Is there a link? Free Radic. Biol. Med. 2018;127:124&#x2013;133. doi: 10.1016/j.freeradbiomed.2018.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.02.030</ArticleId><ArticleId IdType="pubmed">29481840</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehrer S., Rheinstein P.H. The association between selenium, selenoprotein P (SEPP1), fluid intelligence, and exercise in the UK Biobank cohort. Cureus. 2022;14:e25353. doi: 10.7759/cureus.25353.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.25353</ArticleId><ArticleId IdType="pmc">PMC9134928</ArticleId><ArticleId IdType="pubmed">35651983</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweizer U., Bohleber S., Zhao W., Fradejas-Villar N. The Neurobiology of Selenium: Looking Back and to the Future. Front. Neurosci. 2021;15:652099. doi: 10.3389/fnins.2021.652099.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.652099</ArticleId><ArticleId IdType="pmc">PMC7959785</ArticleId><ArticleId IdType="pubmed">33732108</ArticleId></ArticleIdList></Reference><Reference><Citation>Leiter O., Zhuo Z., Rust R., Wasielewska J.M., Gr&#xf6;nnert L., Kowal S., Overall R.W., Adusumilli V.S., Blackmore D.G., Southon A., et al. Selenium mediates exercise-induced adult neurogenesis and reverses learning deficits induced by hippocampal injury and aging. Cell Metab. 2022;34:408&#x2013;423.e8. doi: 10.1016/j.cmet.2022.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2022.01.005</ArticleId><ArticleId IdType="pubmed">35120590</ArticleId></ArticleIdList></Reference><Reference><Citation>Ball H.A., McWhirter L., Ballard C., Bhome R., Blackburn D.J., Edwards M.J., Fleming S.M., Fox N.C., Howard R., Huntley J., et al. Functional cognitive disorder: Dementia&#x2019;s blind spot. Brain. 2020;143:2895&#x2013;2903. doi: 10.1093/brain/awaa224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa224</ArticleId><ArticleId IdType="pmc">PMC7586080</ArticleId><ArticleId IdType="pubmed">32791521</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J., Michalke B., Solovyev N., Grill P., Violi F., Lunetta C., Conte A., Sansone V.A., Sabatelli M., Vinceti M. Elevated Levels of Selenium Species in Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients with Disease-Associated Gene Mutations. Neurodegener. Dis. 2017;17:171&#x2013;180. doi: 10.1159/000460253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000460253</ArticleId><ArticleId IdType="pubmed">28478440</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong L., McCoy M., Komuro H., West X.Z., Yakubenko V., Gao D., Dudiki T., Milo A., Chen J., Podrez E.A., et al. Inflammation-dependent oxidative stress metabolites as a hallmark of amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2021;178:125&#x2013;133. doi: 10.1016/j.freeradbiomed.2021.11.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2021.11.031</ArticleId><ArticleId IdType="pmc">PMC8744315</ArticleId><ArticleId IdType="pubmed">34871763</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharpf M., Schweizer U., Arzberger T., Roggendorf W., Schomburg L., K&#xf6;hrle J. Neuronal and ependymal expression of selenoprotein P in the human brain. J. Neural Transm. 2007;114:877&#x2013;884. doi: 10.1007/s00702-006-0617-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-006-0617-0</ArticleId><ArticleId IdType="pubmed">17245539</ArticleId></ArticleIdList></Reference><Reference><Citation>Solovyev N., Berthele A., Michalke B. Selenium speciation in paired serum and cerebrospinal fluid samples. Anal. Bioanal. Chem. 2012;405:1875&#x2013;1884. doi: 10.1007/s00216-012-6294-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00216-012-6294-y</ArticleId><ArticleId IdType="pubmed">22868477</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito Y., Hayashi T., Tanaka A., Watanabe Y., Suzuki M., Saito E., Takahashi K. Selenoprotein P in Human Plasma as an Extracellular Phospholipid Hydroperoxide Glutathione Peroxidase. J. Biol. Chem. 1999;274:2866&#x2013;2871. doi: 10.1074/jbc.274.5.2866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.5.2866</ArticleId><ArticleId IdType="pubmed">9915822</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S., Caprioli R.M., Hill K.E., Burk R.F. Loss of selenium from selenoproteins: Conversion of selenocysteine to dehydroalanine in vitro. J. Am. Soc. Mass Spectrom. 2003;14:593&#x2013;600. doi: 10.1016/S1044-0305(03)00141-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1044-0305(03)00141-7</ArticleId><ArticleId IdType="pubmed">12781460</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurokawa S., Bellinger F.P., Hill K.E., Burk R.F., Berry M.J. Isoform-specific Binding of Selenoprotein P to the &#x3b2;-Propeller Domain of Apolipoprotein E Receptor 2 Mediates Selenium Supply. J. Biol. Chem. 2014;289:9195&#x2013;9207. doi: 10.1074/jbc.M114.549014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.549014</ArticleId><ArticleId IdType="pmc">PMC3979378</ArticleId><ArticleId IdType="pubmed">24532792</ArticleId></ArticleIdList></Reference><Reference><Citation>Turanov A.A., Everley R.A., Hybsier S., Renko K., Schomburg L., Gygi S.P., Hatfield D.L., Gladyshev V.N. Regulation of Selenocysteine Content of Human Selenoprotein P by Dietary Selenium and Insertion of Cysteine in Place of Selenocysteine. PLoS ONE. 2015;10:e0140353. doi: 10.1371/journal.pone.0140353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0140353</ArticleId><ArticleId IdType="pmc">PMC4599804</ArticleId><ArticleId IdType="pubmed">26452064</ArticleId></ArticleIdList></Reference><Reference><Citation>Hybsier S., Schulz T., Wu Z., Demuth I., Minich W.B., Renko K., Rijntjes E., K&#xf6;hrle J., Strasburger C.J., Steinhagen-Thiessen E., et al. Sex-specific and inter-individual differences in biomarkers of selenium status identified by a calibrated ELISA for selenoprotein P. Redox Biol. 2016;11:403&#x2013;414. doi: 10.1016/j.redox.2016.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2016.12.025</ArticleId><ArticleId IdType="pmc">PMC5220167</ArticleId><ArticleId IdType="pubmed">28064116</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamarche J., Ronga L., Szpunar J., Lobinski R. Characterization and Quantification of Selenoprotein P: Challenges to Mass Spectrometry. Int. J. Mol. Sci. 2021;22:6283. doi: 10.3390/ijms22126283.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22126283</ArticleId><ArticleId IdType="pmc">PMC8230778</ArticleId><ArticleId IdType="pubmed">34208081</ArticleId></ArticleIdList></Reference><Reference><Citation>Rueli R.H., Parubrub A.C., Dewing A.S., Hashimoto A.C., Bellinger M.T., Weeber E.J., Uyehara-Lock J.H., White L.R., Berry M.J., Bellinger F.P. Increased Selenoprotein P in Choroid Plexus and Cerebrospinal Fluid in Alzheimer&#x2019;s Disease Brain. J. Alzheimer&#x2019;s Dis. 2015;44:379&#x2013;383. doi: 10.3233/JAD-141755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-141755</ArticleId><ArticleId IdType="pmc">PMC4419036</ArticleId><ArticleId IdType="pubmed">25298198</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M., Chiari A., Eichmuller M., Rothman K.J., Filippini T., Malagoli C., Weuve J., Tondelli M., Zamboni G., Nichelli P.F., et al. A selenium species in cerebrospinal fluid predicts conversion to Alzheimer&#x2019;s dementia in persons with mild cognitive impairment. Alzheimers Res. Ther. 2017;9:100. doi: 10.1186/s13195-017-0323-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-017-0323-1</ArticleId><ArticleId IdType="pmc">PMC5735937</ArticleId><ArticleId IdType="pubmed">29258624</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.-O., Nordberg A., Backman L.J., Albert M.S., Almkvist O., et al. Mild cognitive impairment&#x2014;beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med. 2004;256:240&#x2013;246. doi: 10.1111/j.1365-2796.2004.01380.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2004.01380.x</ArticleId><ArticleId IdType="pubmed">15324367</ArticleId></ArticleIdList></Reference><Reference><Citation>Limongi F., for the MCI Working Group. Noale M., Bianchetti A., Ferrara N., Padovani A., Scarpini E., Trabucchi M., Maggi S. The instruments used by the Italian centres for cognitive disorders and dementia to diagnose mild cognitive impairment (MCI) Aging. 2018;31:101&#x2013;107. doi: 10.1007/s40520-018-1032-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-018-1032-8</ArticleId><ArticleId IdType="pubmed">30178442</ArticleId></ArticleIdList></Reference><Reference><Citation>McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer&#x2019;s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer&#x2019;s Disease. Neurology. 1984;34:939&#x2013;944. doi: 10.1212/WNL.34.7.939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.34.7.939</ArticleId><ArticleId IdType="pubmed">6610841</ArticleId></ArticleIdList></Reference><Reference><Citation>Tondelli M., Bedin R., Chiari A., Molinari M.A., Bonifacio G., Lelli N., Trenti T., Nichelli P. Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: A clinical cohort study. Clin. Chem. Lab. Med. (CCLM) 2015;53:453&#x2013;460. doi: 10.1515/cclm-2014-0414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2014-0414</ArticleId><ArticleId IdType="pubmed">25274948</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito Y., Misu H., Takayama H., Takashima S.-I., Usui S., Takamura M., Kaneko S., Takamura T., Noguchi N. Comparison of Human Selenoprotein P Determinants in Serum between Our Original Methods and Commercially Available Kits. Biol. Pharm. Bull. 2018;41:828&#x2013;832. doi: 10.1248/bpb.b18-00046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.b18-00046</ArticleId><ArticleId IdType="pubmed">29709922</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>